Literature DB >> 6253491

The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

L M Hallcher, W R Sherman.   

Abstract

myo-Inositol-1-phosphatase has been partially purified from bovine brain. The enzyme has a molecular weight of about 58,000. Both L-myo-inositol 1-phosphate and D-myo-inositol 1-phosphate are hydrolyzed by the enzyme as well as (-)-chiro-inositol 3-phosphate and 2'-AMP. Triphosphoinositide is not a substrate. The phosphatase is completely dependent on Mg2+, which has a Km of 1 mM. Calcium and manganese ions are competitive inhibitors of Mg2+ binding with Ki values of 18 microM and 2 microM, respectively. Lithium chloride inhibits the hydrolysis of both L- and D-myo-inositol 1-phosphate to the extent of 50% at a concentration of 0.8 mM. The phosphatase from testis is similarly inhibited by lithium. Lithium ion is a noncompetitive inhibitor of Mg2+ binding and an uncompetitive inhibitor of myo-inositol 1-phosphate binding. Because lithium chloride administration elicits both an increase in the levels of myo-inositol 1-phosphate and a decrease in the levels of myo-inositol in rat brain (Allison, 1978), and because these actions are blocked by anticholinergic agents, we examined the effects of cholinergic agonists and antagonists on the enzyme and found none. The possibility that the inhibition of this enzyme by lithium ion is related to the pharmacological actions of lithium is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253491

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  213 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

2.  Hydrolysis of inositol phosphates by plant cell extracts.

Authors:  S K Joseph; T Esch; W D Bonner
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

3.  Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures.

Authors:  O Kofman; W R Sherman; V Katz; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Thrombin-induced inositol trisphosphate production by rabbit platelets is inhibited by ethanol.

Authors:  M L Rand; J D Vickers; R L Kinlough-Rathbone; M A Packham; J F Mustard
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

5.  The pharmacogenetics of lithium response depends upon clinical co-morbidity.

Authors:  Troy Bremer; Cornelius Diamond; Rebecca McKinney; Tatyana Shehktman; Thomas B Barrett; Chris Herold; John R Kelsoe
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

6.  Microwave induced stimulation of 32Pi incorporation into phosphoinositides of rat brain synaptosomes.

Authors:  C R Gandhi; D H Ross
Journal:  Radiat Environ Biophys       Date:  1989       Impact factor: 1.925

7.  Inhibition of agonist-stimulated inositol lipid metabolism by the anticonvulsant carbamazepine in rat hippocampus.

Authors:  E E McDermott; S D Logan
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Interactions between lithium, inositol and mono-oleoylglycerol in the regulation of insulin secretion from isolated perifused rat islets.

Authors:  W S Zawalich; K C Zawalich; H Rasmussen
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

9.  Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol.

Authors:  P P Godfrey
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

10.  Pertussis toxin inhibits chemotactic peptide-stimulated generation of inositol phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells.

Authors:  S J Brandt; R W Dougherty; E G Lapetina; J E Niedel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.